Codexis (LTS:0I0X) Investments And Advances : $9.70 Mil (As of Mar. 2024)

View and export this data going back to 2018. Start your Free Trial

What is Codexis Investments And Advances?

Codexis's Investments And Advances for the quarter that ended in Mar. 2024 was $9.70 Mil.

Codexis's quarterly Investments And Advances declined from Sep. 2023 ($18.01 Mil) to Dec. 2023 ($9.70 Mil) but then stayed the same from Dec. 2023 ($9.70 Mil) to Mar. 2024 ($9.70 Mil).

Codexis's annual Investments And Advances increased from Dec. 2021 ($14.00 Mil) to Dec. 2022 ($20.51 Mil) but then declined from Dec. 2022 ($20.51 Mil) to Dec. 2023 ($9.70 Mil).

Codexis Investments And Advances Historical Data

The historical data trend for Codexis's Investments And Advances can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Codexis Investments And Advances Chart

Codexis Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Investments And Advances

Get a 7-Day Free Trial

1.45

14.00

20.51

9.70

Codexis Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Investments And Advances	Get a 7-Day Free Trial															21.31	21.38	18.01	9.70	9.70

Codexis Investments And Advances Calculation

Investments And Advances includes all the non-current investments in affiliates, real estate, securities, etc.

Codexis (LTS:0I0X) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Codexis Inc (LTS:0I0X) » Definitions » Investments And Advances

Comparable Companies

Traded in Other Exchanges

CDXS:USA 4QK:Germany

Address

200 Penobscot Drive, Redwood, CA, USA, 94063

Website

https://www.codexis.com

Codexis Inc is involved in the business of providing enzyme optimization services, commercialization of proteins, and developing biocatalyst products. The firm's products and services include Screening and Evolution services, Enzymes, Screening Kits. It also develops protein engineering and biocatalyst platforms such as Codeevolver, Ketoreductases, Transminases, Imine reductases, etc. The company operates in two business segments namely Performance Enzymes and Novel Biotherapeutics. It generates maximum revenue from the Performance Enzymes segment. Geographically, it derives a majority of revenue from the APAC.

Codexis (LTS:0I0X) Headlines

No Headlines